Is Ki-67 a better proliferative marker in the colon than proliferating cell nuclear antigen?

Cancer Epidemiology Biomarkers and Prevention

Volumn 6, Issue 2, 1997, Pages 131-135

  Holt, Peter R ^a,b   Moss, Steven F ^a   Kapetanakis, Anargyros M ^a   Petrotos, Athanassios ^a   Wang, Shaobai ^a  

^a The New York Presbyterian Hospital   (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; KI 67 ANTIGEN;

AGED; ARTICLE; CANCER SUSCEPTIBILITY; CELL PROLIFERATION; COLON CANCER; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

ADENOMA; ANTIBODIES, MONOCLONAL; CELL DIVISION; COLON; COLONIC NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; KI-67 ANTIGEN; MICROWAVES; PROLIFERATING CELL NUCLEAR ANTIGEN; TUMOR MARKERS, BIOLOGICAL;

EID: 0031013707     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Lipkin, M. Bioraarkers of increased susceptibility to gastrointestinal cancer. Gastroenterology, 92: 1083-1086, 1987.
2. Risio, M., Coverlizza, A., Ferrari, A., Candelaresi, G., and Rossini, F. Immunohistochemical study of epithelial cell proliferation in hyperplastic polyps, adenomas, and adenocarcinomas of the large bowel. Gastroenterology, 94: 899-906, 1988.
3. Lipkin, M. Biomarkers of increased susceptibility to gastrointestinal cancer: new application to studies of cancer prevention in human subjects. Cancer Res., 48: 235-245, 1988.
4. Lipkin, M., Blattner, W., Fraumeni, J., Jr., Lynch, H., Deschner, E., and Winawer, S. Tritiated thymidine (Øp. Øh) labeling distribution as a marker for hereditary predisposition to colon cancer. Cancer Res., 43: 1899-1904, 1983.
5. Bleiberg, H., and Galand, P. In vitro autoradiographic determination of cell kinetic parameters in adenocarcinomas and adjacent healthy mucosa of human colon and rectum. Cancer Res., 36: 325-328, 1976.
6. Kelloff, G., Boone, C., Crowell, J., Steele, V., Lubet, R., and Doody, L. Surrogate end point biomarkers for Phase II cancer chemoprevention trials. J. Cell. Biochem., 19: 1-9, 1994.
7. Risio, M. Methodological aspects of using immunohistochemical cell proliferation biomarkers in colorectal carcinoma chemo-prevention. J. Cell. Biochem., 19 (Suppl.): 61-67, 1994.
8. Dietrich, D. Toxicological and pathological applications of proliferating cell nuclear antigen (PCNA), a novel endogenous marker for cell proliferation. Crit. Rev. Toxicol., 23: 77-109, 1993.
9. Diebold, J., Lai, M., and Lohrs, U. Analysis of proliferative activity in colorectal mucosa by immunohistochemical detection of proliferating cell nuclear antigen (PCNA). Virchows Arch. B Cell Pathol., 62: 283-289, 1992.
10. Einspahr, J., Alberts, D., Xie, T., Ritchie, J., Earnest, D., Hixson, L., Powell, M., Roe, D., and Grogan, T. Comparison of proliferating cell nuclear antigen versus the more standard measures of rectal mucosal proliferation rates in subjects with a history of colorectal cancer and normal age-matched controls. Cancer Epidemiol., Biomarkers & Prev., 4: 359-366, 1995.
11. Richter, F., Richter, A., Yang, K., and Lipkin, M. Cell proliferation in rat colon measured with bromodeoxyuridine, proliferating cell nuclear antigen, and (3H)thymidine. Cancer Epidemiol., Biomarkers & Prev., 1: 561-566, 1992.
12. Risio, M., Candelaresi, G., and Rossini, F. Bromodeoxyuridine uptake and proliferating cell nuclear antigen expression throughout the colorectal tumor sequence. Cancer Epidemiol., Biomarkers & Prev., 2: 363-367, 1993.
13. Cattoretti, G., Becker, M., Key, G., Duchrow, M., Schluter, C., Galle, J., and Gerdes, J. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (Mib-1 and Mib-3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J. Pathol., 168: 357-363, 1992.
14. Steinbach, G., Lupton, J., Reddy, B., Kral, J., and Holt, P. Effect of calcium supplementation on rectal epithelial hyperproliferation in intestinal bypass subjects. Gastroenterology, 106: 1162-1167, 1994.
15. Prioleau J., and Schnitt, S. p53 antigen loss in stored paraffin slides. N. Engl. J. Med., 332: 1521-1522, 1995.
16. Morris, G., and Matthews, M. Regulation of proliferating cell nuclear antigen during the cell cycle. J. Biol. Chem., 264: 13856-13864, 1989.
17. Bravo, R., and MacDonald-Bravo, H. Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: association with DNA replication sites. J. Cell Biol., 105: 1549-1554, 1987.
18. Landberg, G., and Roos, G. Antibodies to proliferating cell nuclear antigen as S-phase probes in flow cylrometric cell cycle analysis. Cancer Res., 51:4570, 1991.
19. Shivji, M., Kenny, M., and Wood, R. Proliferating cell nuclear antigen is required for DNA excision repair. Cell, 69: 367-374, 1992.
20. Lohr, F., Wenz, F., Flentje, M., Peschke, P., and Hahn, E. Comparison of proliferating cell nuclear antigen (PCNA) staining and BrdUrd-labelling index under different proliferative conditions in vitro by flow cytometry. Cell Proliferation, 28: 93-104, 1995.
21. Key, G., Becker, M., Baron, B., Duchrow, M., Schluter, C., Flad, H., and Gerdes, J. New Ki-67-equivalent murine monoclonal antibodies (MIB-1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62-base pair repetitive elements encoding for the Ki-67 epitope. Lab. Invest., 68: 629-636, 1993.
22. Bruno, S., and Darzynkiewicz, Z. Cell cycle-dependent expression and stability of the nuclear protein detected by Ki-67 antibody in HL-60 cells. Cell Proliferation, 25: 31-40, 1992.